DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

IZMO Limited — Press Release

NSE 1 hr ago·7 Oct 2026, 4:19 am

Izmo

IZMO Limited has announced a significant expansion of its partnership with IIT Madras. The company revealed that it has entered the second phase of a ₹99.94 crore program sanctioned by the Ministry of Electronics and Information Technology (MeitY). This initiative focuses on developing silicon photonics technology, which is crucial for high-speed data transmission and optical communication systems.

This development is a positive signal for investors, as it validates IZMO's technical capabilities and strengthens its position in the research and development space. Successfully advancing to Phase II suggests the project is on track and could lead to future commercial applications. Investors should monitor the progress of this program and any subsequent announcements regarding commercialization or partnerships.